A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Part of paid clinical trials in Anaheim, California.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07288567
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
13 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents.

Key Dates

Start date
Jan 29, 2026
Status verified
Jun 2026
Primary completion
Dec 18, 2029
Completion
Dec 18, 2029

Study Design

Enrollment
166 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: KarXT
  • Placebo Comparator: Placebo

Primary Outcome Measure

Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score [ Time Frame: Week 5 ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (18)

FacilityCityStateZIPSite coordinators
Advanced Research Center Inc.AnaheimCalifornia92805
Steven Macina, Site 0077
714-999-6688
Inland Psychiatric Medical Group.ChinoCalifornia91710
Nandita Puchakayala, Site 0058
909-488-9116
Local Institution - 0024Culver CityCalifornia90230
Site 0024
Local Institution - 0083RedlandsCalifornia92373
Site 0083
Local Institution - 0089San FranciscoCalifornia94158
Site 0089
Apg Research, LlcOrlandoFlorida32803
Morteza Nadjafi, Site 0032
407-423-7149
Atlanta Center for Medical ResearchAtlantaGeorgia30331
Elyssa Barron, Site 0057
404-881-5800
Salveo Integrative Health - LawrencevilleLawrencevilleGeorgia30046
Shahzad Hashmi, Site 0106
Denali Health Atlanta, LLCStone MountainGeorgia30083
Maria Johnson, Site 0039
EmVenio Research Center - Prime HealthcareChicagoIllinois60622
Mitchell Glaser, Site 0044
773-620-2995
Local Institution - 0076BostonMassachusetts02115
Site 0076
Local Institution - 0059WorcesterMassachusetts01608
Site 0059
Local Institution - 0061Great NeckNew York11021
Site 0061
University of Cincinnati Dept of Psychiatry and Behavioral NeuroscienceCincinnatiOhio45219
Melissa DelBello, Site 0051
Local Institution - 0113NashvilleTennessee37212
Site 0113
Local Institution - 0046GarlandTexas75043
Site 0046
Local Institution - 0066SpringTexas77381
Site 0066
Local Institution - 0050RichmondVirginia23284
Site 0050

Find similar trials in Anaheim, CA

By condition
Schizophrenia
By specialty
PsychiatryMental healthBehavioral health
By research site
Advanced Research Center Inc.· Anaheim, CAInland Psychiatric Medical Group.· Chino, CALocal Institution - 0024· Culver City, CALocal Institution - 0083· Redlands, CALocal Institution - 0089· San Francisco, CAApg Research, Llc· Orlando, FL

Related Studies